Iatrica Overview

Founded 2007
Status Private
Employees 3
Latest Deal Type Accelerator/​Inc
Investors 1

Iatrica General Information


Developer of immunoconjugates for cancer therapy.The company operates as a biotechnology company which develops immunoconjugates for the treatment of cancer and other infectious disorders.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 855 North . Wolfe Street
  • Suite 613
  • Baltimore, MD 21205
  • United States
+1 (410) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Iatrica Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Profitable

Iatrica Executive Team (2)

Name Title Board Seat Contact Info
Rajani Ravi Ph.D Co-Founder
Atul Bedi MD Co-Founder & President

Iatrica Investors (1)

To view Iatrica‘s full investor history, request access >>
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Johns Hopkins Technology Ventures Accelerator/Incubator 000 0000 000000 0

Ready to get started?

Request a free trial